Identifying genetic risks for autism in newborns
Project 1: Identifying and optimizing monogenetic risk prediction for autism in newborns
This study is looking at how testing newborns' genes can help spot the risk of autism early on, so families can get the right support and treatments sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10916384 on NIH RePORTER |
What this research studies
This research investigates the use of genomic sequencing in newborns to identify genetic risks for autism before symptoms appear. By screening for specific genetic variants associated with autism, the study aims to provide early diagnoses that can lead to timely interventions. The approach involves analyzing the genetic makeup of newborns to predict who may develop autism and how they might benefit from behavioral therapies. This could significantly improve outcomes for infants at risk by allowing for early support and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns, particularly those with a family history of autism or other genetic conditions linked to autism risk.
Not a fit: Patients who are older than four weeks or those without a genetic predisposition to autism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and intervention for infants at risk of developing autism, improving their long-term outcomes.
How similar studies have performed: Other research has shown promise in using genetic screening for early diagnosis of autism, indicating that this approach could be effective.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Chung, Wendy K — Columbia University Health Sciences
- Study coordinator: Chung, Wendy K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.